Ozempic and Rybelsus are approved for type 2 diabetes, and Wegovy is primarily indicated for weight management in obese and overweight patients, when used along with healthy lifestyle modifications and caloric restrictions
Panel a : The proportion of participants achieving total body fat mass reduction thresholds at Week 48 by dual-energy X-ray absorptiometry (DXA) is based on logistic regression with multiple imputation using a treatment-regimen estimand
The most widely prescribed GLP-1 for weight loss
GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists are generally well-tolerated, but like all medications, they can cause side effects
Taurine Often selected to support energy, brain function, and overall balance
Individuals using oral tirzepatide formulations or sublingual tirzepatide face additional bioavailability considerations that make microdose calculations even more complex